NEW YORK (360Dx) – With an anticipated buyers' market resulting from the Protecting Access to Medicare Act, Quest Laboratories went on a spending spree in 2017, announcing or completing 12 acquisitions during the year, or 21 percent of all M&A deals in the diagnostics space, making it the most acquisitive firm in the sector, according to an analysis by 360Dx.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.